BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36320663)

  • 1. An imported human case with the SARS-CoV-2 Omicron subvariant BA.2.75 in Yunnan Province, China.
    Zhang M; Chen Z; Zhou J; Zhao X; Chen Y; Sun Y; Liu Z; Gu W; Luo C; Fu X; Zhao X
    Biosaf Health; 2022 Dec; 4(6):406-409. PubMed ID: 36320663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.
    Parums DV
    Med Sci Monit; 2023 Feb; 29():e939580. PubMed ID: 36722047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic architecture and evolutionary relationship of BA.2.75: A Centaurus subvariant of Omicron SARS-CoV-2.
    Basheer A; Zahoor I; Yaqub T
    PLoS One; 2023; 18(5):e0281159. PubMed ID: 37224159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution melting analysis to discriminate between the SARS-CoV-2 Omicron variants BA.1 and BA.2.
    Koshikawa T; Miyoshi H
    Biochem Biophys Rep; 2022 Sep; 31():101306. PubMed ID: 35791375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk evaluation and mitigation strategies for newly detected SARS-CoV-2 Omicron BF.7 subvariant: A brief report.
    Nazmunnahar ; Ahmed I; Islam MR
    Health Sci Rep; 2023 Mar; 6(3):e1127. PubMed ID: 36875932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importation of SARS-CoV-2 Omicron variant in Beijing, China.
    Li F; Liang Z; Cui S; Lv B; Feng Z; Xu H; Jia L; Yang P; Wang Q; Pan Y; Zhang D
    Biosaf Health; 2022 Jun; 4(3):150-153. PubMed ID: 35463809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75.
    Wang Q; Iketani S; Li Z; Guo Y; Yeh AY; Liu M; Yu J; Sheng Z; Huang Y; Liu L; Ho DD
    Cell Host Microbe; 2022 Nov; 30(11):1512-1517.e4. PubMed ID: 36108630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional characteristics of SARS-CoV-2 Omicron subvariant BA.2 spike.
    Zhang J; Tang W; Gao H; Lavine CL; Shi W; Peng H; Zhu H; Anand K; Kosikova M; Kwon HJ; Tong P; Gautam A; Rits-Volloch S; Wang S; Mayer ML; Wesemann DR; Seaman MS; Lu J; Xiao T; Xie H; Chen B
    bioRxiv; 2022 Apr; ():. PubMed ID: 35547850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global challenge with the SARS-CoV-2 omicron BA.2 (B.1.1.529.2) subvariant: Should we be concerned?
    Roohani J; Keikha M
    World J Virol; 2022 Nov; 11(6):496-501. PubMed ID: 36483099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/Iraq.
    Majed SO; Jalal PJ; Fatah MH; Karim KK; Karim AY; Miasko M; Hasannajad S; Mustafa SA
    Cell Mol Biol (Noisy-le-grand); 2023 Nov; 69(11):56-63. PubMed ID: 38015540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages.
    Xia S; Wang L; Zhu Y; Lu L; Jiang S
    Signal Transduct Target Ther; 2022 Jul; 7(1):241. PubMed ID: 35853878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of mutations defining SARS-CoV-2 Omicron subvariants BA.2.12.1 and BA.4/5 on Spike function and neutralization.
    Pastorio C; Noettger S; Nchioua R; Zech F; Sparrer KMJ; Kirchhoff F
    iScience; 2023 Nov; 26(11):108299. PubMed ID: 38026181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children.
    Setiabudi D; Sribudiani Y; Hermawan K; Andriyoko B; Nataprawira HM
    Front Pediatr; 2022; 10():898463. PubMed ID: 35983081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking the first SARS-CoV-2 Omicron BA.5.1.3 outbreak in China.
    Wang X; Zhu X; Lin Y; He L; Yang J; Wang C; Zhu W
    Front Microbiol; 2023; 14():1183633. PubMed ID: 37275159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of SARS-CoV-2 Omicron subvariants: current situation and future trends.
    Farahat RA; Abdelaal A; Umar TP; El-Sakka AA; Benmelouka AY; Albakri K; Ali I; Al-Ahdal T; Abdelazeem B; Sah R; Rodriguez-Morales AJ
    Infez Med; 2022; 30(4):480-494. PubMed ID: 36482957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events.
    Ou J; Lan W; Wu X; Zhao T; Duan B; Yang P; Ren Y; Quan L; Zhao W; Seto D; Chodosh J; Luo Z; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Apr; 7(1):138. PubMed ID: 35474215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and high-resolution computed tomography findings of 805 patients with mild or moderate infection from SARS-CoV-2 Omicron subvariant BA.2.
    Pan YN; Gu MY; Mao QL; Ruan XZ; Du XF; Gao X; Chen XQ; Li AJ
    Curr Med Imaging; 2023 Apr; ():. PubMed ID: 37170975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance and Analysis of SARS-CoV-2 Variant Importation - China, January-June 2022.
    Feng Y; Zhao X; Yin Z; Wu C; Chen Z; Nie K; A R; Li L; Niu P; Wang J; Wu Y; Wang S; Wang D; Tan W; Wang H; Ma X; Gao GF; Chen C; Xu W
    China CDC Wkly; 2022 Dec; 4(50):1136-1142. PubMed ID: 36751558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 Omicron subvariant spike N405 unlikely to rapidly deamidate.
    Beaudoin CA; Petsolari E; Hamaia SW; Hala S; Alofi FS; Pandurangan AP; Blundell TL; Chaitanya Vedithi S; Huang CL; Jackson AP
    Biochem Biophys Res Commun; 2023 Jul; 666():61-67. PubMed ID: 37178506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.